Neo-Adjuvant Use of Sorafenib for Hepatocellular Carcinoma Awaiting Liver Transplantation. Minoux K, Lassailly G, Ningarhari M, Lubret H, et al. Transpl Int 2022;35:10569.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Minoux K, Lassailly G, Ningarhari M, Lubret H, et al. Neo-Adjuvant Use of Sorafenib for Hepatocellular Carcinoma Awaiting Liver Transplantation. Transpl Int 2022;35:10569.
PMID: 36438781